Literature DB >> 11895853

Flow cytometric analysis of the cell cycle phase specificity of DNA damage induced by radiation, hydrogen peroxide and doxorubicin.

Alan J Potter1, Katherine A Gollahon, Ben J A Palanca, Mary J Harbert, Young M Choi, Alexander H Moskovitz, John D Potter, Peter S Rabinovitch.   

Abstract

We have optimized a flow cytometric DNA alkaline unwinding assay to increase the sensitivity in detecting low levels of DNA damage (strand breaks and alkali-labile sites) and to permit the measurement of the extent of DNA damage within each cell cycle compartment. The lowest gamma radiation dose that induced detectable DNA damage in each cell cycle phase of HeLa and CEM cells was 10 cGy. The lowest H(2)O(2) concentration that induced detectable DNA damage in each cell cycle phase was 0.5 microM in HeLa cells, and 1-2.5 TmicroM in CEM cells. For both HeLa cells and CEM cells, DNA damage in each cell cycle compartment increased approximately linearly with increasing doses of gamma radiation and H(2)O(2). Although untreated HeLa and CEM cells in S phase consistently exhibited greater DNA unwinding than did G(1) or G(2) cells (presumably due to DNA strand breaks associated with replication forks), there was no difference between the susceptibility of G(0)/G(1), S and G(2)/M phase cells to DNA damage induced by gamma radiation or H(2)O(2), or in the rate of repair of this damage. In each cell cycle phase, the susceptibility to gamma radiation-induced DNA damage was greater in CEM cells than in HeLa cells. In contrast to the lack of cell cycle phase-specific DNA damage induced by exposure to gamma radiation or H(2)O(2), the cancer chemotherapeutic drug doxorubicin (adriamycin) predominantly induced DNA damage in G(2) phase cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895853     DOI: 10.1093/carcin/23.3.389

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  16 in total

1.  Prediction of mechanisms of action of antibacterial compounds by gene expression profiling.

Authors:  Bernd Hutter; Christoph Schaab; Sebastian Albrecht; Matthias Borgmann; Nina A Brunner; Christoph Freiberg; Karl Ziegelbauer; Charles O Rock; Igor Ivanov; Hannes Loferer
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Parameiosis in Aspergillus nidulans in response to doxorubicin.

Authors:  T C A Becker; M A A De Castro-Prado
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

3.  Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB.

Authors:  Sunil K Manna; Julie S Bose; Vijay Gangan; Nune Raviprakash; Thota Navaneetha; Pongali B Raghavendra; Banaganapalli Babajan; Chitta S Kumar; Swatantra K Jain
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

4.  Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy.

Authors:  Chien-Hsiang Hsu; Steven J Altschuler; Lani F Wu
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

5.  Synergistic targeting of cell membrane, cytoplasm, and nucleus of cancer cells using rod-shaped nanoparticles.

Authors:  Sutapa Barua; Samir Mitragotri
Journal:  ACS Nano       Date:  2013-09-27       Impact factor: 15.881

6.  The PIM-2 kinase is an essential component of the ultraviolet damage response that acts upstream to E2F-1 and ATM.

Authors:  Shahar Zirkin; Ateret Davidovich; Jeremy Don
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

7.  Cytometric detection of chromatin relaxation, an early reporter of DNA damage response.

Authors:  H Dorota Halicka; Hong Zhao; Monika Podhorecka; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2009-07-11       Impact factor: 4.534

8.  A dynamic view of chemotherapy effectiveness.

Authors:  Yunpeng Liu; Michael T Hemann
Journal:  Nature       Date:  2019-08       Impact factor: 49.962

9.  Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.

Authors:  Renee C Geck; Jackson R Foley; Tracy Murray Stewart; John M Asara; Robert A Casero; Alex Toker
Journal:  J Biol Chem       Date:  2020-03-05       Impact factor: 5.157

10.  Human epidermal growth factor receptor 2-positive breast cancer: which cytotoxic agent best complements trastuzumab's efficacy in vitro?

Authors:  Tracey Hurrell; Kim Outhoff
Journal:  Onco Targets Ther       Date:  2013-06-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.